ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study

Volume: 13, Issue: 1
Published: Jan 8, 2021
Abstract
Background Blood-based biomarkers for Alzheimer’s disease (AD) are highly needed in clinic practice. So far, the gold standards for AD diagnosis are brain neuroimaging and beta-amyloid peptide, total tau, and phosphorylated tau in cerebrospinal fluid (CSF); however, they are not attractive for large-scale screening. Blood-based biomarkers allow an initial large-scale screening of patients under suspicion that could later be tested for the...
Paper Details
Title
ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study
Published Date
Jan 8, 2021
Volume
13
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.